Zobrazeno 1 - 10
of 1 659
pro vyhledávání: '"Prolymphocytic leukemia"'
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Orphan diseases, exemplified by T-cell prolymphocytic leukemia, present inherent challenges due to limited data availability and complexities in effective care. This study delves into harnessing the potential of machine learning to enhance c
Externí odkaz:
https://doaj.org/article/90398e76b4344e84a69e1bb2fecbacf6
Autor:
Hilde K. Gjelberg, Lars Helgeland, Knut Liseth, Francesca Micci, Miriam Sandnes, Hege G. Russnes, Håkon Reikvam
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 10007-10018 (2023)
T-prolymphocytic leukemia (T-PLL) is a rare malignancy of mature T-cells with distinct clinical, cytomorphological, and molecular genetic features. The disease typically presents at an advanced stage, with marked leukocytosis, B symptoms, hepatosplen
Externí odkaz:
https://doaj.org/article/6248a833b81a4966a9b67e5e2a9ad5e7
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 53-54 (2024)
Externí odkaz:
https://doaj.org/article/3cc77eaa886c412bb3c18e1bed3bdcff
Autor:
Naoki Okada, Ryusuke Yamamoto, Hayato Maruoka, Mayuko Himeno, Nobuhiro Hiramoto, Takayuki Ishikawa
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 604-612 (2023)
T-cell prolymphocytic leukemia (T-PLL) is a rare aggressive disease with a poor prognosis. Allogeneic stem cell transplantation (allo-SCT) followed by alemtuzumab administration is the most promising treatment for T-PLL but is associated with a high
Externí odkaz:
https://doaj.org/article/46dc5f994c1a435e8bf84e4556da82fd
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 562-570 (2023)
We present a case of lymphocytosis assumed and managed initially as a chronic lymphocytic leukemia. Shortly after initial visit, the patient’s condition deteriorated rapidly with hepatosplenomegaly, pleural effusion, ascites, and skin lesions. Flow
Externí odkaz:
https://doaj.org/article/bc6aa1cbbce54f8db498611c945c3fad
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTBackground: T-prolymphocytic leukemia (T-PLL) is an aggressive hematologic malignancy. A portion of patients can be cured with alemtuzumab induction followed by allogeneic hematopoietic stem cell transplant, but patients who relapse after tra
Externí odkaz:
https://doaj.org/article/2fab398806a24985a9f7976cb6305edf
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 84-88 (2022)
This article demonstrates case report and review of literature of successful use Campath-IH in T-cell prolymphocytic leukemia.
Externí odkaz:
https://doaj.org/article/800483449d8847ffaa760488792c4c8f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Musa Makongoro, Mahmoud Matar Mohammad Abu Rakhey, Yafei Yu, Jianzhi Sun, Guosheng Li, Na He, Samir Ali Abd El-Kaream, Daoxin Ma
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 23, Iss 1, Pp 1-7 (2022)
Abstract Background The B-cell prolymphocytic leukemia (B-PLL) diagnosis is challenging due to the superposition with mature B-cell leukemia and/or lymphoma. Objective An insight case study of trisomy 5 with complex karyotype abnormalities in B-cell
Externí odkaz:
https://doaj.org/article/744f89c1cd6d495180312988d31d8713
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.